Support for Medical Institutions Moving Towards Relaxed Visitation Rules in Response to the FY2026 Medical Fee Revision – PR TIMES

News Highlights

In anticipation of the FY2026 medical fee revision, initiatives are emerging to support medical institutions in relaxing their visitation policies. This revision has the potential to impact the management strategies and business succession plans of medical institutions, with particular focus likely to be placed on economies of scale and the utilization of tax schemes. Consideration will be needed for transitioning to specific medical corporations or social medical corporations to leverage tax incentives.

M&A Medical Editorial Department’s Perspective

The news about supporting relaxed visitation policies in response to the FY2026 medical fee revision is not merely about easing infection control measures. Medical fee revisions directly affect the revenue structure of medical institutions. Therefore, supporting relaxed visitation at this juncture is presumed to be a strategy to compensate for potential revenue decreases post-revision by enhancing patient satisfaction through the lifting of visitation restrictions and by developing new services accordingly. For individual medical institutions, the burden of capital investment and securing personnel can be significant. Thus, this situation could serve as an impetus to consider M&A or business succession to benefit from economies of scale through group formation, thereby maintaining facility standards and distributing the burden of new capital investments. In particular, utilizing tax schemes with a view to transitioning to specific medical corporations or social medical corporations directly impacts the reduction of tax burdens after succession, making early consultation with experts essential.

Key Issues Highlighted by This News

• The integration of medical fee revisions with “patient services” like relaxed visitation, incorporated into management strategies.
• The potential for economies of scale to motivate M&A and business succession by maintaining facility standards and reducing capital investment burdens.
• The impact of tax schemes, aimed at transitioning to specific medical corporations or social medical corporations, on post-succession profitability.
• The possibility of support for relaxed visitation acting as a catalyst for promoting DX in medical institutions and building new revenue models.

Practical Questions Arising from This News

• What are the specific services offered to support relaxed visitation?
• Are there specific simulations available on how relaxed visitation will affect revenue under the medical fee revision?
• What kind of tax benefits can be expected from group formation?

If You Feel “Should I Consult Too?”

As seen in this news, cases where external factors like medical fee revisions influence patient services such as relaxed visitation, and consequently impact management strategies and the timing of business succession, are expected to increase. Particularly when economies of scale and tax schemes are involved, M&A and business succession become viable options if independent measures are difficult. By aligning your institution’s management status with the impact of the revision and consulting with experts early on, you can identify the optimal succession and development strategy.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as an M&A support institution certified by the Small and Medium Enterprise Agency, on a full success fee basis. Consultations are handled with strict confidentiality. Free consultations are available here.